Delisting riskPopularity #4,581
ADIL · NASDAQ · Biotechnology

Adial Pharmaceuticals (ADIL)

Develops precision-oriented therapies for ulcerative colitis and genetically selected alcohol use disorder patients.

$4.02
vs last close−0.18 (−4.29%)